Medicine and Dentistry
Patient
100%
Neoplasm
45%
Disease Free Survival
41%
Diagnosis
32%
Colon Cancer
29%
Surgery
27%
Overall Survival
26%
Inpatient
23%
Hazard Ratio
22%
Survival
22%
Recurrent Disease
20%
Lymph Node
20%
Therapeutic Procedure
20%
Computed Tomography
18%
Cyclophosphamide
18%
Needle Biopsy
18%
Diseases
18%
Lesion
16%
Malignant Neoplasm
15%
Cetuximab
15%
Excision
15%
Portography
14%
Intraductal Carcinoma
12%
Colorectal Cancer
12%
Surgeon
12%
Anal Cancer
12%
Lymph Duct
12%
Programmed Cell Death
12%
Gene
12%
Atypical Ductal Hyperplasia
12%
Protein P53
11%
Hereditary Colorectal Cancer
10%
Hyperplasia
10%
Specimen
10%
Association
10%
Metastatic Carcinoma
9%
Docetaxel
9%
Follow up
9%
Incidence
9%
FOLFOX
9%
Liver
9%
Biopsy
9%
Base
8%
Carcinogenesis
8%
Cancer Syndrome
8%
Adiponectin
8%
Cryotherapy
8%
Sentinel Lymph Node
8%
Glycon
8%
Silibinin
8%
Biochemistry, Genetics and Molecular Biology
Genome Instability
21%
Polymerase Chain Reaction
21%
P53
17%
Cancer Cell
15%
Mutation
15%
Colon
14%
Inter Simple Sequence Repeat
13%
Development
12%
Nested Gene
12%
Tumor Progression
9%
KRAS
8%
Association
8%
Cetuximab
7%
Perfusion
6%
Survival
6%
Carcinogenesis
6%
Wild Type
6%
ErbB
5%
Disease Free Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Colon Cancer
24%
Neoplasm
19%
Colorectal Cancer
17%
Adverse Event
10%
Chemotherapy
9%
Disease Free Survival
8%
Adiponectin
8%
Silibinin
8%
Tumor Growth
8%
Anus Cancer
8%
Cetuximab
8%
Carcinogenesis
7%
Recurrent Disease
7%
Docetaxel
6%
Fluorouracil
5%
Toxicity
5%
Survival
5%
Overall Survival
5%